Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.529 +0.009 (+0.36%)

Streaming Delayed Price Updated: 1:45 PM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

August 07, 2023

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms

From GeneDx Holdings Corp.; PacBio

Via GlobeNewswire

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

The Latest Analyst Ratings for Pacific Biosciences ↗

August 03, 2023

Via Benzinga

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

Analyst Ratings for Pacific Biosciences ↗

June 30, 2023

Via Benzinga

Where Pacific Biosciences Stands With Analysts ↗

June 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

Time To Play Small Cap Life Science Stocks ↗

May 15, 2023

The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.

Via Talk Markets

Expert Ratings for Pacific Biosciences ↗

May 04, 2023

Via Benzinga

Pacific Biosciences (NASDAQ: PACB) Making Surprising Moves in Friday Session

March 31, 2023

Via Investor Brand Network

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗

May 10, 2023

Via Benzinga

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

Cathie Wood Scoops Up AMD Stock On A Day When It Tanks Over 9%: Also Raises Stake In This Biotech Company ↗

May 03, 2023

Via Benzinga

Earnings Outlook For Pacific Biosciences ↗

February 15, 2023

Via Benzinga

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Biotech And Life Science Trades: Q1 2023 Performance By The Numbers ↗

April 01, 2023

Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

Rumble, TORM And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

March 31, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

SMID Cap Life Science Update: Are You An Investor Or Trader? ↗

February 20, 2023

Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.

Via Talk Markets

Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week ↗

February 10, 2023

These cutting-edge biotech companies quickly fell out of favor with investors this week.

Via The Motley Fool

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

Why Pacific Biosciences Of California Shares Are Trading Higher Today ↗

January 09, 2023

Pacific Biosciences of California (PacBio) (NASDAQ: PACB) shares are trading higher today after the company announced it received orders for 76 Revio systems in the fourth quarter of 2022. The company...

Via Benzinga

Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday ↗

November 16, 2022

U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.